Black Diamond Therapeutics Statistics
NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.83+0.03 (+1.67%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Black Diamond Therapeutics by the numbers
Black Diamond Therapeutics has a market capitalization of $104.9 million based on 57.30M shares outstanding. With trailing EPS of $-0.75, Black Diamond Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 19.1% below its 200-day average.
Average daily trading volume is 624.92K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BDTX valuation vs. peer median
| Metric | BDTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $104.86M | $91.56M | +15% |
| Avg. volume | 624.92K | 798.71K | -22% |
Peer median across 8 companies: ATRA, LENZ, ENGN, CGTX, NMRA, TNYA, CRDF, PTHS.
Valuation
- Market cap
- $104.86M
- EPS (TTM)
- $-0.75
- Shares outstanding
- 57.30M
Price and trading
- Previous close
- 1.80
- Open
- 1.79
- Day range
- 1.78 – 1.87
- 52-week range
- 1.60 – 4.94
- 52-week change
- -53.20%
- Beta
- —
- Volume
- 562.61K
- Average volume
- 624.92K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 104.86M
- Forward Pe
- -1.83
- Eps
- -0.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.94
- Week52 Low
- 1.60
- Avg Volume
- 624.92K
- Shares Outstanding
- 57.30M
- Ma50
- 1.98
- Ma200
- 2.26
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -62.96%
- Pct From52w Low
- 14.38%